July 31 (Reuters) - Telix Pharmaceuticals Ltd (TLX) :
- BLA FILING UPDATE FOR RENAL CANCER IMAGING AGENT TLX250-CDX
- US FDA NOT ACCEPTED BIOLOGICS LICENSE APPLICATION FOR TLX250-CDX
(([email protected];))
News: TLX Telix Pharmaceuticals Says US FDA Not Accepted Biologics License Application For...
Add TLX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$23.47 |
Change
0.130(0.56%) |
Mkt cap ! $7.855B | |||
| Open | High | Low | Value | Volume |
| $23.82 | $23.99 | $23.23 | $28.94M | 1.231M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 2801 | $23.46 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $23.50 | 7000 | 1 |
View Market Depth
| Last trade - 16.10pm 12/11/2024 (20 minute delay) ? |
| TLX (ASX) Chart |